Clinical Trial Update: A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

View source ↗

Summary

A pilot study evaluating tumor-derived exosomes as diagnostic and prognostic markers in breast cancer patients receiving neoadjuvant chemotherapy has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Leo W. Jenkins Cancer Center | Conditions: Breast Neoplasms | Status: WITHDRAWN